CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Mednet Launches NCI SBIR/STTR-Funded TrialMatch to Accelerate Cancer Clinical Trial Discovery

Positive
AI Analysis

Summary

Mednet announced TrialMatch, an AI-powered clinical trial discovery tool designed to help oncologists identify relevant cancer trials more efficiently. The tool is funded by NCI SBIR/STTR program.

Importance:3/10
Sentiment:
0.40
clinical trialsoncologyAI/machine learningtrial discoverySBIR/STTR funding

Read the original article

Published by PR Newswire Pharma on August 20, 2026 11:00 AM

Read Original